<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01480440</url>
  </required_header>
  <id_info>
    <org_study_id>CMU2010-28E</org_study_id>
    <nct_id>NCT01480440</nct_id>
  </id_info>
  <brief_title>Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System</brief_title>
  <official_title>Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Should System Used in Primary or Revision Reverse Total Shoulder Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to obtain survival and outcome data on the Trabecular Metal&#xD;
      Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to obtain survival and outcome data on the Trabecular Metal&#xD;
      Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.&#xD;
      This will be done by analysis of standard scoring systems, radiographs and adverse event&#xD;
      records. Data will be collected and analyzed to monitor pain, function, and survivorship and&#xD;
      to confirm the performance of the Trabecular Metal Reverse Shoulder System.&#xD;
&#xD;
      Performance will be evaluated by monitoring the frequency and incidence of adverse events as&#xD;
      well as by assessment of the overall pain and functional performances, survivorship, health&#xD;
      status and radiographic parameters of all enrolled study subjects who receive the Trabecular&#xD;
      metal Reverse Shoulder System.&#xD;
&#xD;
      Pain and functional performance will be measured using the American Shoulder and Elbow&#xD;
      Surgeons (ASES) Shoulder Assessment and the Single Assessment Numeric Evaluation (SANE),&#xD;
      survivorship will be based on removal or intended removal of the device, health status will&#xD;
      be determined by evaluation of the Short Form Survey12 (SF-12) as well as Adverse Events&#xD;
      (AEs) and radiographic parameters analysis of x-rays.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 2011</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survivorship</measure>
    <time_frame>10 Years</time_frame>
    <description>Based on removal or intended removal of the device and determined using the Kaplan-Meier method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain and Functional Performance</measure>
    <time_frame>10 Years</time_frame>
    <description>Measurements will be based on the American Shoulder and Elbow Surgeons (ASES) Shoulder Assessment and the Single Assessment Numeric Evaluation (SANE)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Post-traumatic Arthritis</condition>
  <condition>Ununited Humeral Head Fracture</condition>
  <condition>Irreducible 3-and 4-part Proximal Humeral Fractures</condition>
  <condition>Avascular Necrosis</condition>
  <condition>Gross Rotator Cuff Deficiency</condition>
  <condition>Revision Total Shoulder Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Trabecular Metal Reverse Shoulder System</arm_group_label>
    <description>Patients requiring primary or revision reverse total shoulder arthroplasty who receive the Trabecular Metal Reverse Shoulder System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trabecular Metal Reverse Shoulder System</intervention_name>
    <description>Trabecular Metal Reverse Shoulder System used in primary or revision total shoulder arthroplasty</description>
    <arm_group_label>Trabecular Metal Reverse Shoulder System</arm_group_label>
    <other_name>TM Reverse Shoulder System</other_name>
    <other_name>TM Reverse System</other_name>
    <other_name>TM Reverse</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Each investigator will screen from his/her patients who suffer from osteoarthritis,&#xD;
        rheumatoid arthritis, post-traumatic arthritis, ununited humeral head fracture,&#xD;
        irreduciable 3-and 4-part proximal humeral fractures, avascular necrosis, gross rotator&#xD;
        cuff dificiency or failed total shoulder arthroplasty (both glenoid and humeral components&#xD;
        require revision) who meet the inclusion/exclusion criteria stated in the protocol&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is &gt; 18 years of age;&#xD;
&#xD;
          -  Patient is skeletally mature;&#xD;
&#xD;
          -  Patient qualifies for primary or revision unilateral or bilateral reverse total&#xD;
             shoulder arthroplasty based on physical exam and medical history including the&#xD;
             following: osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, ununited&#xD;
             humeral head fracture, irreducible 3-and 4-part proximal humeral fractures, avascular&#xD;
             necrosis, gross rotator cuff deficiency or failed total shoulder arthroplasty (both&#xD;
             glenoid and humeral components require revision);&#xD;
&#xD;
          -  Patient is willing and able to provide written informed consent;&#xD;
&#xD;
          -  Patient is willing and able to cooperate in the required post-operative therapy;&#xD;
&#xD;
          -  Patient is willing and able to complete scheduled follow-up evaluations/questionnaires&#xD;
             as described in the Informed Consent;&#xD;
&#xD;
          -  Patient has participated in the Informed Consent process and has signed the&#xD;
             Institutional Review Board (IRB)/Ethical Review Board (ERB) approved informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is a prisoner;&#xD;
&#xD;
          -  The patient is mentally incompetent or unable to understand what participation in the&#xD;
             study entails;&#xD;
&#xD;
          -  The patient is a known alcohol or drug abuser;&#xD;
&#xD;
          -  The patient is anticipated to be non-compliant;&#xD;
&#xD;
          -  The patient has one of the following compromising the affected limb: a significant&#xD;
             injury to the upper brachial plexus, paralysis of the axillary nerve or a&#xD;
             neuromuscular disease compromising the affected limb which would render the procedure&#xD;
             unjustifiable;&#xD;
&#xD;
          -  The patient has a local/systemic infection;&#xD;
&#xD;
          -  The patient is known to be pregnant;&#xD;
&#xD;
          -  The patient has marked bone loss;&#xD;
&#xD;
          -  The patient has a known sensitivity or allergic reaction to one or more of the&#xD;
             implanted materials;&#xD;
&#xD;
          -  The patient is unwilling or unable to give consent or to comply with the follow-up&#xD;
             program.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kacy Arnold, RN, MBA</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Orthopaedic &amp; Sports Medicine</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Rothman Institute</name>
      <address>
        <city>Egg Harbor Township</city>
        <state>New Jersey</state>
        <zip>08234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Blackburn Hospital</name>
      <address>
        <city>Blackburn</city>
        <state>Lancashire</state>
        <zip>BB2 3HH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 23, 2011</study_first_submitted>
  <study_first_submitted_qc>November 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2011</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reverse Total Shoulder Arthroplasty (TSA)</keyword>
  <keyword>Reverse TSA</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>Post-traumatic arthritis</keyword>
  <keyword>Ununited humeral head fracture</keyword>
  <keyword>Irreducible 3-and 4-part proximal humeral fractures</keyword>
  <keyword>Avascular necrosis</keyword>
  <keyword>Gross rotator cuff deficiency</keyword>
  <keyword>Failed total shoulder arthroplasty</keyword>
  <keyword>Revision total shoulder arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Humeral Fractures</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

